Alsius files to sell up to $40.25 million of stock in IPO

New York, April 26 - Alsius Corp. plans to offer up to $40.25 million of common stock in an initial public offering, according to an S-1 filing with the Securities and Exchange Commission.

RBC Capital Markets is bookrunner for the sale with Harris Nesbitt as joint lead manager and Leerink Swann & Co. as co-manager.

The proposed Nasdaq National Market symbol for the shares is "ICEY."

Alsius is an Irvine, Calif., maker of devices to precisely control patient temperature in hospital critical care settings.

Its products include a comprehensive suite of catheter-based intravascular temperature management products that address an unmet clinical need for effective, accurate, easy-to-use and cost-effective control of body temperature in critical care patients.

Proceeds from the IPO will be used for sales and marketing, manufacturing, research and development and general corporate purposes.

For 2005, Alsius reported a net loss of $10.12 million on revenue of $3.22 million. The previous year, the net loss was $8.22 million on revenue of $1.64 million.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.